November 4, 2026
Mechanical thrombectomy is one of the most transformative advancements in modern emergency neurovascular medicine, capable of reversing severe neurological deficits caused by acute ischemic stroke. During this minimally invasive endovascular procedure, an interventional specialist navigates micro-catheters through the arterial system directly to the brain, physically capturing and removing a blood clot to restore cerebral blood flow.
However, mechanical thrombectomy is not suitable for every stroke. Deciding whether a patient is a candidate requires rapid, multi-tiered clinical and neuroimaging evaluations performed within minutes of arrival at an emergency neurovascular center.
Mechanical thrombectomy is specifically engineered to treat strokes caused by a Large Vessel Occlusion (LVO)—a clot lodged within one of the brain’s major arterial highways. Tiny blood vessels deep within the brain tissue cannot physically accommodate thrombectomy catheters and are treated with medical management instead.
Emergency teams utilize immediate CT Angiography (CTA) or Magnetic Resonance Angiography (MRA) to determine if a clot is obstructing a major vessel, including:
If an occlusion is confirmed in one of these accessible large vessels, the patient moves forward in the evaluation process.
For years, endovascular stroke intervention was restricted to a strict 6-hour window from the moment symptoms began. Groundbreaking clinical trials expanded this window up to 24 hours from “last known well” for qualifying patients.
Neurovascular teams assess two primary clinical timeframes:
A successful thrombectomy requires that the brain tissue downstream from the clot is still alive. If the affected brain territory has already undergone irreversible cell death (infarction), re-opening the blood vessel will not restore neurological function and can trigger dangerous bleeding into the dead tissue (reperfusion hemorrhage).
To evaluate tissue viability, neurovascular teams rely on advanced software and specialized imaging:
On an initial non-contrast CT scan, physicians evaluate the brain using the ASPECTS system—a 10-point scale evaluating early signs of ischemic damage in the middle cerebral artery territory:
In extended-window cases, automated perfusion imaging maps blood transit times across the brain to separate two distinct zones:
If imaging reveals a clinical-radiographic mismatch—meaning a relatively small core of dead tissue surrounded by a large, salvageable penumbra—the patient is an ideal candidate for mechanical thrombectomy, even many hours after the stroke began.
In addition to imaging, doctors evaluate the physical severity of the stroke using the National Institutes of Health Stroke Scale (NIHSS). This standardized 42-point clinical examination assesses levels of consciousness, eye movements, visual field loss, facial symmetry, arm and leg motor strength, sensory function, speech clarity, and spatial neglect.
Finally, physicians account for the patient’s baseline neurological and physical function prior to the acute event. Evaluated using the Modified Rankin Scale (mRS), patients who were functionally independent prior to the stroke have the highest likelihood of achieving meaningful recovery following thrombectomy.
Additionally, the team confirms that the patient does not have severe active internal bleeding, uncontrolled severe hypertension, or massive intracranial hemorrhage that would make endovascular navigation unsafe.
Once these criteria align, the neuroendovascular team mobilizes immediately to extract the clot, stop the progression of brain cell loss, and maximize the patient’s chances of a full recovery.